Parkinson's Disease - May 2, 2024 - Diet's impact on gut bacteria offers new clues in Parkinson's disease management

Can't see this email? View it online

	Parkinson's Disease
	The latest Parkinson's disease news from News Medical

	Diet's impact on gut bacteria offers new clues in Parkinson's disease management Researchers find that diet significantly influences the gut microbiome in Parkinson's disease patients, potentially affecting disease progression and symptoms.

	Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation and protect brain cells in Parkinson’s. NLRP3 is a protein that plays a role in regulating a number of inflammatory processes that are believed to contribute to the damage to brain cells that underlies Parkinson’s.

Genetic characteristics that influence the risk of Parkinson's disease (PD) due to pesticide exposure.

	U of T researchers develop new approach for controlling neuron generation in Parkinson's disease Researchers at the University of Toronto have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with no cure and few effective treatments.

	Genetic variants linked to Parkinson's risk from pesticide exposure A new UCLA Health study found certain genetic variants could help explain how long-term pesticide exposure could increase the risk of Parkinson's disease.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions